These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


425 related items for PubMed ID: 17341540

  • 21. First clinical experience with isradipine in the treatment of hypertension in Portugal.
    Rocha-Gonçalves F, Mariano-Pego G, Viegas J, Correia JM, Botelho MA.
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S4-6. PubMed ID: 1720485
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I.
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [Abstract] [Full Text] [Related]

  • 25. Aliskiren: renin inhibitor for hypertension management.
    Cheng JW.
    Clin Ther; 2008 Jan; 30(1):31-47. PubMed ID: 18343241
    [Abstract] [Full Text] [Related]

  • 26. Tolerability of long-term treatment with lercanidipine versus amlodipine and lacidipine in elderly hypertensives.
    Leonetti G, Magnani B, Pessina AC, Rappelli A, Trimarco B, Zanchetti A, COHORT Study Group.
    Am J Hypertens; 2002 Nov; 15(11):932-40. PubMed ID: 12441211
    [Abstract] [Full Text] [Related]

  • 27. [Evaluation of psychosomatic symptomatology in hypertensive patients treated with lercanidipine (LERCAPSICO study)].
    Abellán Alemán J, Martínez García JF, Merino Sánchez J, Gil Guillén V, Latorre Hernández J, Fernández Montero F, Navarro Lima A, Grupo de Investigaciones del Estudio LERCAPSICO.
    An Med Interna; 2003 Jun; 20(6):287-91. PubMed ID: 12848598
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Lercanidipine: a review of its use in hypertension.
    McClellan KJ, Jarvis B.
    Drugs; 2000 Nov; 60(5):1123-40. PubMed ID: 11129125
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: an 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial.
    Kim SH, Chung WY, Zo JH, Kim MA, Chang HJ, Cho YS, Youn TJ, Chae IH, Choi DJ, Gwak JJ, Lee HY, Park JS, Kang HJ, Kim YJ, Kim HS.
    Clin Ther; 2009 May; 31(5):988-98. PubMed ID: 19539099
    [Abstract] [Full Text] [Related]

  • 32. Use of calcium channel blockers in hypertension.
    Conlin PR, Williams GH.
    Adv Intern Med; 1998 May; 43():533-62. PubMed ID: 9506192
    [Abstract] [Full Text] [Related]

  • 33. Comparative effects of lercanidipine, lacidipine, and nifedipine gastrointestinal therapeutic system on blood pressure and heart rate in elderly hypertensive patients: the ELderly and LErcanidipine (ELLE) study.
    Cherubini A, Fabris F, Ferrari E, Cucinotta D, Antonelli Incalzi R, Senin U.
    Arch Gerontol Geriatr; 2003 May; 37(3):203-12. PubMed ID: 14511846
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The role of fixed-dose combinations in the management of hypertension: focus on lercanidipine-enalapril.
    Chatzikyrkou C, Haller H, Menne J.
    Expert Opin Pharmacother; 2009 Aug; 10(11):1833-40. PubMed ID: 19527194
    [Abstract] [Full Text] [Related]

  • 36. Tolerability of isradipine in the treatment of mild-to-moderate hypertension in general practice: a large-scale surveillance study.
    Hermans L, Bogaert M, Degaute JP, Rorive G, Six R, Bara L, Lanssiers P, De Keyser P, Westelinck KJ.
    J Cardiovasc Pharmacol; 1992 Aug; 19 Suppl 3():S38-45. PubMed ID: 1376833
    [Abstract] [Full Text] [Related]

  • 37. [Drug information about lercanidipine. A new dihydropyridine calcium antagonist for the treatment of arterial hypertension].
    Christensen KL.
    Ugeskr Laeger; 2005 Jan 10; 167(2):153-5. PubMed ID: 15697124
    [No Abstract] [Full Text] [Related]

  • 38. Fixed-dose combination lercanidipine/enalapril.
    Hair PI, Scott LJ, Perry CM.
    Drugs; 2007 Jan 10; 67(1):95-106; discussion 107-8. PubMed ID: 17209666
    [Abstract] [Full Text] [Related]

  • 39. [Some aspects of the clinical use of lercamen (lercadipine)].
    Kavtaradze GV, Kostava MT, Gvetadze LG.
    Georgian Med News; 2009 Jan 10; (172-173):50-3. PubMed ID: 19644190
    [Abstract] [Full Text] [Related]

  • 40. Lercanidipine and losartan effects on blood pressure and fibrinolytic parameters.
    Lin TH, Voon WC, Yen HW, Huang CH, Su HM, Lai WT, Sheu SH.
    Kaohsiung J Med Sci; 2006 Apr 10; 22(4):177-83. PubMed ID: 16679299
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 22.